Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Validation of Physical Activity Assessment in Type 1 Diabetes – an Essential Step to Incorporating Systematic Measurement of Activity as the Standard of Care in Youth

Liz Tim Davis Jones MBBS FRACP PhD MBBS DCH FRACP MD Co-director of Children’s Diabetes Centre Co-head, Diabetes and Obesity Research Co-director of

Celebrating Elders this NAIDOC Week

Family: Children are a gift, born from country into a family, ancestry and culture as enduring as the universe.

Leading youth mental health researchers welcome sector funding

Leaders of Western Australia’s youth mental health research sector from Embrace at The Kids Research Institute Australia have welcomed the state government’s $420 million boost to mental health spending in its 2023-24 budget.

Youth mental health researchers present at ABC science talk

Youth mental health researchers present at ABC science talk

Participation in the Wellbeing and Engagement collection in South Australian schools

In South Australian schools, students in Grade 4 to 12 are invited to participate in an annual survey about their wellbeing and engagement in school, referred to as the Wellbeing and Engagement Collection.

Senior Research Fellow – Early Years Initiative (CoLab)

The Opportunity CoLab is a partnership between The Kids Research Institute Australia and the Minderoo Foundation. CoLab's mission is to bring

Active books for active kids!

Walk through the jungle, hunt for the bear, or do the animal bop this Book Week! Acting out stories is a wonderful way to encourage active play with your child.

Individual, Social, and Environmental Correlates of Energy Drink Use Among Adolescents

To investigate the correlates of adolescent energy drink use using a socioecological approach to inform future interventions.

Moderate and severe diabetic ketoacidosis at type 1 diabetes onset in children over two decades: A population-based study of prevalence and long-term glycemic outcomes

To investigate in a population-based pediatric cohort: prevalence of moderate-severe diabetic ketoacidosis at type 1 diabetes diagnosis over two decades and its association with long-term glycemic control.

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

Hematopoietic cell transplantation (HCT) is an effective treatment for pediatric patients with high-risk, refractory, or relapsed acute myeloid leukemia (AML). However, a large proportion of transplanted patients eventually die due to relapse. To improve overall survival, we propose a combined strategy based on cord blood (CB)-HCT with the application of AML-specific T cell receptor (TCR)-engineered T cell therapy derived from the same CB graft.